Excitingly, our results suggest a new link between DQ treatment and JUN pathway downregulation, which may underscore the beneficial effects of DQ in NP and AF tissues, paving way for future studies to investigate this mechanism. The gene discussed is JUN; the disease is atrial fibrillation.